Catalyst Wire Dossier Catalyst Wire Dossier

Nedaplatin

nedaplatin
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Nedaplatin, covering 2009-02-20 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma [Phase 2]

See pricing